Conferences & Events > Annual Scientific Meeting > Program > Speaker Bios

2019 Annual Scientific Meeting and Satellite Sessions - Speakers

New Frontiers in Medical Toxicology: Pharmacogenomics and Precision Medicine

Russ B. Altman, MD, PhD

Professor of Bioengineering, Genetics, Medicine, and Biomedical Data Science, Stanford University

altman.jpegRuss Biagio Altman is a professor of bioengineering, genetics, medicine, and biomedical data science (and of computer science, by courtesy) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing and informatics technologies to problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels. His lab studies how human genetic variation impacts drug response (e.g., Other work focuses on the analysis of biological molecules to understand the actions, interactions and adverse events of drugs (e.g., He helps lead an FDA-supported Center of Excellence in Regulatory Science & Innovation.

Dr. Altman holds an AB from Harvard College, and an MD from Stanford Medical School, and a PhD in Medical Information Sciences from Stanford. He received the U.S. Presidential Early Career Award for Scientists and Engineers and a National Science Foundation CAREER Award. He is a fellow of the American College of Physicians (ACP), the American College of Medical Informatics (ACMI), the American Institute of Medical and Biological Engineering (AIMBE), and the American Association for the Advancement of Science (AAAS). He is a member of the National Academy of Medicine (formerly the Institute of Medicine, IOM). He is a past-president, founding board member, and a fellow of the International Society for Computational Biology (ISCB), and a past-president of the American Society for Clinical Pharmacology & Therapeutics (ASCPT). He has chaired the Science Board advising the FDA commissioner, currently serves on the NIH Director’s Advisory Committee, and is cochair of the IOM Drug Forum. He is an organizer of the annual Pacific Symposium on Biocomputing, and a founder of Personalis, Inc. Dr. Altman is board certified in Internal Medicine and in Clinical Informatics. He received the Stanford Medical School graduate teaching award in 2000 and mentorship award in 2014.

Kelly Caudle, PharmD, PhD

CPIC Director, St. Judes Children's Research Hospital

caudle.jpgKelly E. Caudle, Pharm.D., Ph.D., BCPS is the Clinical Pharmacogenetics Implementation Consortium (CPIC) Director. CPIC provides guidelines that enable the translation of genetic laboratory test results into actionable prescribing decisions for specific drugs. To date, CPIC has published 21 gene-based clinical guidelines. In this position, Dr. Caudle oversees the CPIC guideline development process including the coordination of the guideline writing committees, the guideline evidence reviews, and the writing of the guideline manuscript and supplement. Furthermore, Dr. Caudle is involved in the clinical implementation of pharmacogenetics at St. Jude Children's Research Hospital.

Dr. Caudle received her Pharm.D. and Ph.D. from The University of Tennessee Health Science Center and completed an ASHP-accredited PGY2 residency at Le Bonheur Children’s Research Hospital. She is also a board‐certified Pharmacotherapy Specialist. Dr. Caudle is currently an affiliate Assistant Professor at The University of Tennessee Health Science Center.

Alison Chubb, PhD

Senior Product Scientist, 23andMe

no_avatar.jpgAlison Chubb is a Senior Product Scientist at 23andMe, where she helps envision, design, and develop genetic health reports. Alison currently focuses on pharmacogenetics and played a key role in the recent FDA authorization of the 23andMe Pharmacogenetics Reports. More generally, she is committed to helping people understand how genetics may impact their health by communicating the most up-to-date science in clear, concise, and consumer-friendly language.

Alison earned her A.B. in English from Princeton University and her Ph.D. in Integrative Biology from the University of California at Berkeley, where she specialized in evolutionary genetics.

Steven Curry, MD

Professor of Emergency Medicine, Internal Medicine and Biomedical Informatics

no_avatar.jpgComing soon.

Will Heise, MD

Assistant Professor, University of Arizona College of Medicine - Phoenix

heise.jpgWill Heise, MD, is a medical toxicologist and family physician. He earned his MD from the University of Iowa. He completed a residency in family medicine and a fellowship in medical toxicology at Banner – University Medical Center Phoenix. His teaching and research interests include critical care toxicology, precision medicine and clinical decision support. He practices with the Department of Medical Toxicology at Banner – University Medical Center and Phoenix Children’s Hospital. He directs the Precision Medicine Theme at the College of Medicine – Phoenix.

A. Min Kang, MD, MPhil

Assistant Professor of Child Health and Medicine, University of Arizona College of Medicine - Phoenix; Chief, Section of Precision and Genomic Medicine, Department of Medical Toxicology, Banner – University Medical Center Phoenix

amkang.jpgDr. Kang is chief of the Section of Precision and Genomic Medicine in the BUMCP Department of Medical Toxicology, as well as the Section of Medical Toxicology at Phoenix Children’s Hospital. He is also associate medical director of the Banner Poison and Drug Information Center. His interests include pharmacogenomics in poisoning/overdose, poison prevention, and addiction medicine.

Teri Manolio, MD, PhD

Director, Division of Genomic Medicine, National Human Genome Research Institute

no_avatar.jpgDr. Manolio directs NHGRI’s Division of Genomic Medicine, where she leads programs to develop and implement genomic applications in clinical care. She came to NHGRI from the National Heart, Lung, and Blood Institute where she was heavily involved in large cohort studies such as the Cardiovascular Health Study, the Framingham Heart Study, and the Multi-Ethnic Study of Atherosclerosis. She moved to NHGRI in 2005 to lead efforts in applying genomic technologies to population research, including the Electronic Medical Records and Genetics (eMERGE) Network, the NHGRI Genome-Wide Association Catalog, the Implementing Genomics in Practice (IGNITE) Network, and the Clinical Genome (ClinGen) Resource. She continues to practice and teach internal medicine at the Walter Reed National Military Medical Center and the Uniformed Services University of the Health Sciences.  She is the author of over 280 research publications and has research interests in genome-wide association studies of complex diseases, ethnic differences in disease risk, and incorporating genomic findings into clinical care.

Andrew Monte, MD, PhD

Associate Professor Emergency Medicine and Medical Toxicology, University of Colorado 

Monte.jpgDr. Monte performs research in drug effectiveness and safety in acute care settings. He directs the Emergency Medicine Specimen Bank, which aims to consent and enroll every patient seen in the University of Colorado Emergency Department to improve the way Emergency Medicine is practiced. He coordinates the Pgx Dissemination Working Group in an effort to improve awareness of PGx resources available through groups such as CPIC, PharmGKB, PharmVar, and the PGRN. Additionally, Dr. Monte's research examines the public health impacts of substance abuse though integration of clinical data available through a robust data warehouse linked with biologic samples gathered through his research program. Dr. Monte has expertise in genetics, assay development, and data integration.

Daniel Mueller, MD, PhD

Professor, Psychiatry and Pharmacology & Toxicology, University of Toronto

online_Daniel_Muller_1_-_A2.jpgThe overarching goal of my research is to identify and clinically validate genes which allow to predict plasma levels, response and side effects to antidepressant and antipsychotic medications. I have published more than 190 peer-reviewed articles with major focus on psychiatric pharmacogenetics and have received recognition as international expert in this field. My publications also address clinical implications and implementation models of pharmacogenetics in clinical practice. I am regularly invited to develop expert guidelines in collaboration with the Clinical Pharmacogenomics Implementation Consortium (CPIC). Based on my contributions in the field of pharmacogenetics, I have received the Klerman Prize by the Brain and Behaviour Research Foundation and the Innovation in Psychopharmacology Award by the Canadian College of Neuropsychopharmacology.

I am currently a Clinician Scientist at the Centre for Addiction and Mental Health (Toronto) and Professor at the Department of Psychiatry and Pharmacology & Tocxicology at the University of Toronto.

Ayrn O'Connor, MD, FACMT

Director, University of Arizona College of Medicine- Phoenix, Medical Toxicology Fellowship

Pic_OConnor_copy.jpgDr. O'Connor currently serves as the Associate Fellowship Director at Banner—University Medical Center in Phoenix, Arizona. She actively participates in the graduate medical education of medical students, residents and fellows as well as providing clinical care for the patients encountered through a busy admitting and consulting medical toxicology service. She holds an appointment as Associate Professor in Emergency Medicine at the University of Arizona -College of Medicine where she is active in providing the pharmacology curriculum to the first, second and third year medical students. Furthermore, she is responsible for the fourth year medical student and resident toxicology elective offered at Banner—University Medical Center. She graduated from Franklin College in 1996 with a bachelor’s degree in Chemistry. In 2000, she earned her M.D. from Indiana University School of Medicine. She completed her residency and fellowship at Indiana University in Emergency Medicine and Toxicology in 2003 and 2005, respectively. Dr. O’Connor joined the faculty at Banner—University Medical Center in 2005 as a clinical toxicologist and educator and is board certified in emergency medicine and toxicology.

Meghan Spyres, MD

Assistant Professor of Clinical Emergency Medicine, University of Southern California

spy.jpgMeghan Spyres attended medical school at Columbia University College of Physicians and Surgeons in New York City and stayed in New York to complete an Emergency Medicine residency at Bellevue/NYU. She completed her Medical Toxicology fellowship training in 2016 at Banner—University Medical Center in Phoenix, Arizona. She is currently Assistant Professor of Clinical Emergency Medicine. Her research interests include rattlesnake envenomations, emerging drugs of abuse, Free Open Access Medical Education (FOAM), and the intersection of critical care and toxicology. She is co-founder of Women in Toxicology, a group that promotes women in academic medicine.

Michelle Whirl-Carrillo, PhD

Coming Soon

no_avatar.jpgComing Soon.

Legal Cannabis: Medical, Toxicological and Public Health Implications

Neal L. Benowitz, MD

Professor of Medicine, University of California

Benowitz.jpgNeal L. Benowitz, MD, is Professor of Medicine and Bioengineering & Therapeutic Sciences, and Chief of the Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco (UCSF). He received his medical degree from the University of Rochester School of Medicine in 1969, following which he served as a resident in internal medicine at the Bronx Municipal Hospital Center from 1969 to 1971. He then completed a postdoctoral fellowship in clinical pharmacology at UCSF and joined the faculty in 1974. His research interests have focused primarily on the human pharmacology and toxicology of nicotine, and has also published a number of papers on the human pharmacology of cannabis. Dr Benowitz also maintains an active clinical practice in cardiovascular medicine and medical toxicology.

Eike Blohm, MD

Assistant Professor, University of Vermont

Blohm.jpgEike Blohm attended Johns Hopkins, class of 2012. He then went to the University of Massachusetts Emergency Medicine Residency. After, he attended the University of Massachusetts Toxicology Fellowship. 

Shelley DuTeaux, PhD, MPH

Chief, Human Health Assessment, California Department of Pesticide Regulation

DuTeaux.jpgShelley DuTeaux is Chief of the Human Health Assessment Branch in the California Department of Pesticide Regulation (DPR). In this role, Dr. DuTeaux provides oversight and guidance in the evaluation of human health effects of pesticides and the scientific basis for pesticide use, regulation, and mitigation activities in the state. She employs a staff of 35 scientists who review toxicity data and conduct risk and exposure analysis for all conventional and biochemical pesticides used in California. Prior to joining DPR, Dr. DuTeaux worked for 15 years in emergency preparedness and response for the California Department of Public Health, the California Air Resources Board, and the California Office of Environmental Health Hazard Assessment. As a subject matter expert on acute and high concentration exposures, Dr. DuTeaux evaluated toxic air releases and assessed the public health impacts of wildfires, train derailments, and industrial explosions and fires, and has contributed to federal and state response plans for chemical warfare agent release. Dr. DuTeaux has a broad range of environmental health experience including in the areas of lead poisoning prevention, solvent toxicity, and quantitative exposure analysis. She is also a former staff member at Los Alamos National Laboratory where she analyzed systemic plutonium distribution kinetics and dose reconstruction from World War II-era human studies. Dr. DuTeaux holds a BA in Communications (University of New Mexico), a Masters in Public Health (University of California, Berkeley), and a PhD in Pharmacology & Toxicology (University of California, Davis).

Matthew Fedoruk, PhD

Chief Science Officer, US Anti-Doping Agency (USADA)

Fedoruk.jpgDr. Matthew Fedoruk currently works as the Chief Science Officer at the U.S. Anti-Doping Agency (USADA). With more than 10 years of experience in anti-doping and a Ph.D. in Pathology and Laboratory Medicine,  Dr. Fedoruk also serves as a standing member of the IPC Anti-Doping Committee, the WADA TDSSA Expert Group Chair and Athlete Biological Passport (ABP) Ad-Hoc Working Group. Before joining USADA, Dr. Fedoruk worked at the Canadian Centre for Ethics in Sport (CCES) and served with the Vancouver 2010 Organizing Committee for the 2010 Olympic and Paralympic Winter Games in Canada. He currently lives in sunny Colorado Springs, Colorado, which is also known as ‘Olympic Town USA’ for being home to the U.S. Olympic Committee, the high-altitude Olympic Training Center, numerous national sport federations and USADA.

David Grelotti, MD

Medical Director, University of California Center for Medicinal Cannabis Research

Grelotti.jpgDr. Grelotti is an Associate Professor of Psychiatry at the University of California San Diego and the Medical Director of the University of California Center for Medicinal Cannabis Research (CMCR). An adult and child psychiatrist, he graduated from medical school at the Johns Hopkins University School of Medicine and completed residency training in the Harvard Medical School Combined Pediatrics, Adult Psychiatry, and Child Psychiatry Residency Training Program at Massachusetts General Hospital and McLean Hospital. With colleagues at the CMCR, he is currently conducting a study of cannabis-related driving impairment, a randomized, placebo-controlled clinical trial of cannabis for low back pain, and investigations of the impact of cannabinoids on the endocannabinoid system in bipolar disorder, HIV, and healthy persons. His research is funded by the National Institutes of Health and the State of California.

Kennon Heard, MD, PhD

Professor of Emergency Medicine, University of Colorado School of Medicine

Heard.jpgKennon Heard is a Professor of Emergency Medicine and Section Chief of Medical Pharmacology and Toxicology at the University of Colorado School of Medicine. He is faulty at the Rocky Mountain Poison and Drug Center and teaches emergency medicine and toxicology at the Univeristy of Colorado Hospital and Children's Hospital Colorado. He is a Fellow of ACMT

Bradley King, PhD, MPH, CIH

Senior Industrial Hygienist, CDC/NIOSH

King.jpgBradley King is a senior industrial hygienist (IH) at the National Institute for Occupational Safety and Health (NIOSH). He joined NIOSH in 1999 as an IH in the Health Hazard Evaluation program in Cincinnati, Ohio; since 2013, he has worked in NIOSH’s Western States Division in Denver, Colorado. He holds a BS in Biology from Loyola University New Orleans, an MPH in Environmental and Occupational Health from Saint Louis University, and a PhD in Environmental Health Science from Johns Hopkins University. He received his commission as an Environmental Health Officer in the United States Public Health Service in 2002 and currently holds the rank of Captain. He received his certification in the comprehensive practice of industrial hygiene in 2005.  Bradley currently serves as a Director on the Board of Directors for the American Industrial Hygiene Association.

Michael J. Kosnett, MD, MPH, FACMT

Associate Clinical Professor, University of Colorado School of Medicine, and Colorado School of Public Health

kosnett.jpgDr. Kosnett is an Associate Clinical Professor in the Division of Clinical Pharmacology and Toxicology at the University of Colorado School of Medicine, an Associate Adjunct Professor in the Department of Environmental and Occupational Health at the Colorado School of Public Health, and an Attending Physician at the Rocky Mountain Poison and Drug Center. He is board certified in internal medicine, occupational medicine, and medical toxicology. Dr. Kosnett has held numerous leadership positions and national appointments as a medical toxicologist, including service as President of the American College of Medical Toxicology, member of the Committee on Toxicology of the National Academy of Sciences, and consultant for the US EPA, the Department of Defense, CDC, the Agency for Toxic Substances and Disease Registry, and the World Health Organization. In 2016, he received the Matthew J. Ellenhorn Award from the American College of Medical Toxicology in recognition of his career achievement.

Recently in Colorado, Dr. Kosnett has been extensively engaged in public health matters related to medical and recreational cannabis. He worked extensively with stakeholders to design and implement the first regulations nationwide requiring that cannabis products be sold in child-resistant packaging. He recently served on the Colorado Department of Revenue’s Marijuana Enforcement Division workgroups the dosage equivalency of cannabis products and their packaging and labeling requirements. He has served on the Colorado Department of Public Health and Environment Pediatric Exposure Prevention Guidelines Committee, and as a technical consultant to the state’s Retail Marijuana Public Health Advisory Committee regarding the pharmacology of cannabinoids. Dr. Kosnett has also offered scientific consultation to multiple stakeholders regarding the impact of cannabis use on workplace and transportation safety. He has spoken on the issue of cannabis-related biomonitoring and performance at national scientific meetings, including those convened by U.S. Anti-Doping Agency, the American College of Occupational and Environmental Medicine, the American College of Medical Toxicology, and the American Industrial Hygiene Association.

In April 2017, Dr. Kosnett began work as Co-Principal Investigator on a 3 year research projected funded by the Colorado Department of Public Health and Environment entitled “Comparative Assessment of Driving Impairment in Occasional versus Heavy Marijuana Users.”

Kara Lynch, PhD, DABCC

Associate Professor, University of California San Francisco

lynch.jpgDr. Kara Lynch is an Associate Professor of Laboratory Medicine at the University of California San Francisco and the Co-Director of the Core Laboratory (Clinical Chemistry and Toxicology) at Zuckerberg San Francisco General Hospital and Trauma Center. She received her PhD in Biochemistry from the University of Wisconsin and did a post-doctoral fellowship in Clinical Chemistry in the COMACC approved training program at UCSF. Her primary area of research is in Clinical Toxicology. Her laboratory conducts studies aimed at identifying and quantifying toxins, drugs of abuse and adulterants in biological specimens using mass spectrometry and correlating the findings with clinical pathologies.

Mike Lynn, MD

Assistant Clinical Professor Emergency Medicine, University of California, San Francisco; CEO and Co-Founder, Hound Labs, Inc.

Lynn.jpegMike is the CEO and Co-Founder of Hound Labs, Inc., a scientific device company which has developed and patented the Hound® marijuana breathalyzer – the world’s first handheld device for rapidly, accurately, and inexpensively measuring the level of THC in breath. A practicing emergency medicine physician and teacher at a premier trauma center in Oakland, CA, Mike is also a clinical faculty member at the University of California, San Francisco. In addition to being an ER physician, Mike worked for 10 years as a venture capitalist specializing in medical devices and biotechnology. A former White House Fellow and Fulbright Scholar with an extensive background in public policy and public health, Mike is currently a reserve deputy sheriff and a fully qualified and active SWAT team member.

Luke N. Rodda, PhD

Chief Forensic Toxicologist and Director, Forensic Laboratory Division, San Francisco Office of the Chief Medical Examiner

rodda.jpgAppointed as Chief Forensic Toxicologist & Director, Forensic Laboratory Division at the Office of the Chief Medical Examiner for the City and County of San Francisco, Dr. Rodda provides toxicological interpretation, expert court testimony & oversees all forensic division operations. He is involved with the analytical method development and validation, analysis and reporting of alcohol, drugs and poisons for over 13 years, and was a Forensic Toxicologist at the Victorian Institute of Forensic Medicine.

Dr. Rodda received a Ph.D. from the Dep of Forensic Medicine at Monash University. He obtained a Bachelor of Applied Sciences in Pharmaceutical Sciences from RMIT University with a First Class Honours in nanotoxicology research awarded.

Professional societies positions include Novel Psychoactive Substances Committee member and Young Scientist Committee member for TIAFT, Oral Fluid DUID committee member and Diversity Committee member for SOFT, Novel Psychoactive Substances Chair for CAT, and membership of CAC, FACTA, ANZFSS, and both the American and Australian AAFS societies.

As an invited Californian state-mandated Drug Impaired Driving Taskforce member, member of County Sexual Assault Response and Preventions groups, and National and regional Drug Death Expert Groups, he actively promotes harm reduction in DUID, DFSA and Drug Deaths within the community.

He holds an Assistant Adjunct Professor position at the University of California, San Francisco, and supervises students from various universities, publishes and reviews papers in peer-reviewed journals, and has presented at national & international conference proceedings.

Susan Tapert, PhD

Professor of Psychiatry, UC San Diego

Tapert.jpgDr. Tapert’s research focuses on brain development and adolescent substance use. She has led 16 NIH-funded projects, including a brain imaging study that recruited 295 youth prior to the initiation of substance use and followed them for 15 years. Dr. Tapert has significantly contributed to literature in her field, publishing 170 peer-reviewed articles in journals including American Journal of Psychiatry, Brain Imaging and Behavior, Neuropsychopharmacology, and Addiction, as well as 118 abstracts and 44 book chapters and review articles. She has been featured as a subject-matter expert in outlets such as USA Today, BBC Radio, the New York Times, National Public Radio and ABC News.

Dr. Tapert is associate director and site principal investigator for the Adolescent Brain Cognitive Development (ABCD) Study, the largest longitudinal study ever conducted on brain development and child health in the U.S. UC San Diego is the Coordinating Center for the 21 nationwide institutions partnering to recruit and track the biological and behavioral development of 11,000 children from age 9 or 10 through adolescence and into young adulthood. Dr. Tapert is scientific director and site PI for the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA), a multi-site, NIH National Institute on Alcohol Abuse and Alcoholism-funded consortium that enrolled and follows 831 youth across five sites.

2019 ACMT Annual Scientific Meeting

Badria Al Hatali, MD

Head of Poison Control Section, Ministry of Health

alhatali.pngDr Al Hatali  is the head of the poison control section,at environmental and occupational health department, at the Ministry of Health in Oman. She also serves as the Middle East and North Africa Association of Medical Toxicology (MENATOX) Treasurer. She is an Acting consultant in the Emergency Medicine Department at Royal Hospital. She  graduated from  Oman Medical Specialty Board in 2012 as well as  certified by the Arab Emergency Medicine Board. She finished her Post Doctoral Fellowship in medical toxicology at Emory University and the Georgia Poison Center  in Atlanta, GA USA in 2014. She has lectured in countries around the world and has awards to her credit. Dr Al Hatali often teaches at the Oman Medical Speciality Board in Oman and has a true passion for Toxicology.

Maryann Amirshahi, PharmD, MD, MPH

Emergency Medicine Physician, MedStar Washington Hospital Center

no_avatar.jpgMaryann Amirshahi completed her PharmD at the University of the Sciences in Philadelphia, followed by medical school at Temple University. She completed her emergency medicine residency at the Hospital of the University of Pennsylvania, medical toxicology fellowship at the George Washington University, and clinical pharmacology fellowship at Children’s National Medical Center. She also received an MPH from the George Washington University focusing on environmental and occupational health. She is board certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology. She is an Assoicate Professor of Emergency Medicine at the Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center and Children’s National Medical Center. She serves as a toxicology consultant for the Mid-Atlantic Center for Children’s Health and the Environment and the National Capital Poison Center. Her research interests include medication safety, medical toxicology, drug shortages, and prescription drug abuse.

Ashish Bhalla, MD

Post Graduate Institute of Medical Education and Research

Bhalla.jpgI am Dr Ashish Bhalla, professor of Internal Medicine at post graduate institute of medical education and research, Chandigrah, a premier tertiary care medical institute in North Western India. I am an internist with more than 25 years of teaching experience in teaching undergraduates and post graduate students. i am a trained toxicologist with fellowship in clinical toxicology from St Thoma's hospital London under the guidance of Prof Paul Dargan. I have been a board member and secretary for Asia Pacific Association of Medical Toxicology (APAMT) for 4 years and am will take over as President of APAMT on 1st January 2019. i have been a member of the EXTRIP group and also the Lipid rescue group. i have published extensively in the field of organophosphates, aluminium phsophide and snake envenomation. I have been actively associated with ACMT and CDC for management of chemical emergencies and disaster training in India. I have been a visiting faculty to various universities in USA, Canada and Australia.

Rana Biary, MD

Medical Toxicology Fellowship Director, NYU/Bellevue Hospitals

biary.pngRana Biary did her Emergency Medicine residency at Cornell/Columbia and her Toxicology fellowship at NYU/Bellevue. She is currently the Medical Toxicology fellowship director at NYU where her interests include curriculum development, mentorship, and physician wellness. Having spent her most of her childhood living abroad, she identifies as a "Third Culture Kid" and loves to spend her free time traveling and meeting new people.

Paul D. Blanc, MD, MSPH

Professor of Medicine and the Endowed Chair in Occupational and Environmental Medicine, University of California San Francisco

Blanc.jpgDr. Paul D. Blanc MD MSPH is Professor of Medicine and holds the Endowed Chair in Occupational and Environmental Medicine at the University of California San Francisco. Blanc received his BA from Goddard College (Plainfield, Vermont), where he first became interested in health and the environment, later training at the Harvard School of Public Health (in industrial hygiene), the Albert Einstein School of Medicine, and Cook County Hospital (in a joint Occupational Medicine and Internal Medicine Residency). He was a Robert Wood Johnson Clinical Scholar at UCSF from 1985-7 and a Fulbright Senior Research Scholar at the Ben Gurion University of the Negev in 1987-8. He has been a resident scholar at the Rockefeller Bellagio Center (Bellagio, Italy) and the American Academy in Rome. In 2013-4, he was a fellow at the Center for Advanced Studies in the Behavioral Sciences at Stanford University. In 2016, he was awarded an Honorary Doctorate from the Sahlgrenska Medical Academy, Gothenburg, Sweden. Blanc has authored numerous scholarly publications in his field and is the author of How Everyday Products Make People Sick (University of California Press, 2009) and Fake Silk: The Lethal History of Viscose Rayon (Yale University Press, 2016 ). Fake Silk received the Viseltear Prize from the American Public Health Association, for “Outstanding Book on the History of Public Health” in 2017. Blanc also has written a blog, “Household Hazards,” hosted by the magazine Psychology Today.

Joseph Carpenter, MD

Emory University

no_avatar.jpgComing Soon.

Stephanie Carreiro, MD, MSPH

Assistant Professor, University of Massachusetts Medical School

Carreiro.pngStephanie Carreiro, MD is an emergency medicine physician and medical toxicologist. She is a 2009 graduate of New York Medical College and completed her Emergency Medicine Residency in 2013 at Brown University before pursuing a medical toxicology fellowship at the University of Massachusetts.   In 2015 she joined the Division of Medical Toxicology at the University of Massachusetts as an Assistant Professor of Emergency Medicine.  Dr. Carreiro has a passion for novel translational research, which she first discovered during residency while evaluating novel antidotes for cardiotoxicity in animal models.  She now focuses on the integration of wearable technology with behavioral interventions in the treatment of substance abuse disorders.   Her current research interests include the utilization of of wearable biosensors and microRNA profiles to evaluate drug toxicity, substance, abuse and addiction. She is currently a University of Massachusetts Mentored Career Development Award KL2 scholar, and is also pursuing a PhD in Biomedical Sciences from the University of Massachusetts.

Peter R. Chai, MD, MMS

Emergency Medicine Physician, Brigham and Women's Hospital

Chai.jpgDr. Peter R Chai is an Emergency Medicine Physician and Medical Toxicologist at Brigham and Women’s Hospital and Harvard Medical School, and adjunct faculty at The Fenway Institute. He is a graduate of the Warren Alpert Medical School at Brown University where he also did his residency in Emergency Medicine. After completing his fellowship in medical toxicology at the University of Massachusetts Medical School, Dr. Chai is currently funded by the National Institute on Drug Abuse to develop digital health interventions that respond to varying Pre-exposure prophylaxis adherence patterns among men who have sex with men with stimulant use. His other investigations include understanding the underlying mechanisms and use of music to address pain and opioid use, and wearable biosensors to detect changes in physiologic state among emergency department patients.

Brenna Farmer, MD, MSc, MBAc

Attending Physician, Weill Cornell Medicine

farmer.JPGDr. Brenna Farmer is an attending physician in the Department of Emergency Medicine at Weill Cornell Medicine. Her clinical work occurs at New York Presbyterian Hospital's Weill Cornell and Lower Manhattan Hospital campuses. She works as a consultant for the Medical Toxicology Consultation Service at both sites. Her interests include acute bedside care of the poisoned patient, adverse medication events and medication safety.

Kimberlie Graeme, MD, FACMT

Medical Toxicologist, Banner University Medical Center - Phoenix

Graeme_Kimberlie.jpgDr. Graeme is an Associate Professor of Emergency Medicine at the College of Medicine – Phoenix and the Assistant Director of the Medical Toxicology Fellowship at the Banner – University Medical Center Phoenix. Her interests include natural toxins as well as suicide and poisoning prevention.


Rachel Haroz, MD

Assistant Professor of Emergency Medicine, Cooper Medical School of Rowan University

Rachel_20Haroz.jpgRachel Haroz MD FAACT is Assistant Professor in the Department of Emergency Medicine at Cooper Medical School of Rowan University.  She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine, obtaining her BA in Biology from Brandeis University, her MD from Tufts University and completed a residency in Emergency Medicine and fellowship in Medical Toxicology at MCP/Hahnemann. She has spent the last 17 years working in inner city emergency departments, mostly in the Camden area where opioid intoxication, abuse and dependency are rampant.  She helped launch and now staffs the Outreach Clinic at the Urban Health Institute at Cooper University Hospital in Camden New Jersey, an addiction medicine specialty clinic dedicated to treating patients with substance use disorders as well as the Early Intervention Program Clinic – a clinic dedicated to the care of patients with HIV and substance use disorders.  In the last 2 years she helped created and implement an initiative to prescribe buprenorphine from the Emergency Department and bridge patients to treatment.  She is also heavily involved in education of residents, medical students and pharmacists and organizes education forums focused on topics related to opioid dependency and treatment, having received grant funding to achieve this.  She works closely with local government and emergency provider organizations such as the EMS staff and the Camden County Addiction Drug Task Force in both education and intervention initiatives.

Keith Humphreys, PhD

Esther Ting Memorial Professor, Stanford University

humphreys.jpgKeith Humphreys is the Esther Ting Memorial Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He is also a Senior Research Career Scientist at the VA Health Services Research Center in Palo Alto and an Honorary Professor of Psychiatry at the Institute of Psychiatry, King's College, London. His research addresses the prevention and treatment of addictive disorders, the formation of public policy and the extent to which subjects in medical research differ from patients seen in everyday clinical practice.

For his work in the multinational humanitarian effort to rebuild the psychiatric care system of Iraq and in the national redesign of the VA health system's mental health services for Iraq war veterans, he won the 2009 American Psychological Association Award for Distinguished Contribution to the Public Interest. He and the authors of "Drug Policy and the Public Good" won the 2010 British Medical Association's Award for Public Health Book of the Year.

Dr. Humphreys has been extensively involved in the formation of public policy, having served as a member of the White House Commission on Drug Free Communities, the VA National Mental Health Task Force, and the National Advisory Council of the U.S. Substance Abuse and Mental Health Services Administration. During the Obama Administration, he spent a sabbatical year as Senior Policy Advisor at the White House Office of National Drug Control Policy. He has also testified on numerous occasions in Parliament and advises multiple government agencies in the U.K.

Bryan Judge, MD

Medical Toxicologist, Emergency Care Specialists

Judge_Photo.jpgBryan Judge practices Emergency Medicine and Medical Toxicology in Grand Rapids, MI and Emergency Medicine in Laurium, MI. He is currently an Associate Professor in the Department of Emergency Medicine, College of Human Medicine - Michigan State University.

 Ziad Kazzi, MD

Associate Professer of Emergency Medicine, Emory University

Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University. He is also the assistant medical director of the Georgia Poison Center and directs the Environmental and Occupational Toxicology clinic at Grady Health System.
As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. He is currently serving as a board member of the American College of Medical Toxicology and chairs its International Committee and the Clerkship Council for Medical Toxicology. Dr. Kazzi has extensively lectured at National and International conferences and developed several curricula and training programs in emergency preparedness and response. He is an active and founding board member of the Middle East North Africa Toxicology Association and currently serves as its president

Le Quang Thuan, MD, PhD, FACMT

Vice Director, Poison Control Center, Bach Mai Hospital

Dr. Le Quang Thuan is working at the Poison Control Center (PCC) of Bach Mai hospital - a multi-field medical facility in Hanoi and is considered as one of the largest in Vietnam. He received his PhD in Clinical Medicine from 108 Institute of Clinical Medical and Pharmaceutical Sciences, Master Degree in Internal Medicine from Vietnam Military Medical University, Degree of General Medicine at Hanoi Medical University; and Certificate of Diplome Inter Universitaire Urgences Medicales et Chirurgicales et de Catastrophes. Along with his FACMT, he is a member of Vietnam Association of Emergency Critical Care Medicine and Medical Toxicology, Asia Pacific Association of Medical Toxicology, Society of Toxicology, and American Society for Apheresis.

He has been working as Medical Toxicologist and Critical Care Specialist from 2009 up to now at the PCC, the only biggest and famous poison control center for not only treatment, clinical researches but also training and education in Vietnam. He and his colleagues of the PCC have treated approximately 2000 patients annually in which many of them were severe poisoned patients and accumulated experiences and successes in the field of treatments for agricultural chemicals such as organophosphate, paraquat, nereistoxin poisoning; bee stings and thousands cases of snakebite including Naja, King cobra, Krait and Viper; severe lead poisonings; amatoxin, ochratoxin A and methanol poisoning outbreaks; drug abuses and other kinds of toxins etc. A lot of researches and technique about emulsified charcoal, snake antivenoms, gastric lavage with closed circuit, plasma exchange, continuous veno-venous hemofiltration and hemoperfusion were effectively carried out and applied in the center. Training courses on management of poisonings for Vietnamese and international doctors from around the world also are often taught here.

Dr. Thuan particularly interests in researches about toxin-induced hepatic injury and blood purification in toxicology where he indeed had a successful study about the role of suitable combination of aggressive plasma exchange with other therapies in the treatment of severe toxic hepatitis.

He and his colleagues continuously promote better treatment practice and protocol, researches, training and education in medical toxicology not only domestic but also for international cooperation.


JoAn Laes, MD

Addiction Medicine Physician, Hennepin Healthcare

Laes.pngJoAn Laes, MD, Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN; Core Medical Toxicology Faculty, Minnesota Poison Control System, Minneapolis, MN; Medical Director, Mission Detox Center, Plymouth, MN and 1800 Detox, Minneapolis, MN, ASAM Medical Toxicology Workgroup Chair, ACMT Addiction Medicine Committee Co-chair
Dr. Laes' practice is focused on inpatient addiction medicine and toxicology consultation and outpatient treatment of opioid and other substance use disorders. She is board certified in Internal Medicine, Addiction Medicine, and Medical Toxicology. She completed internal medicine residency at Hennepin Healthcare and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Elissa Moore, DO

Assistant Professor of Emergency Medicine, University of Southern California

moore.jpgDr. Moore is currently an Assistant Professor of Emergency Medicine in the Division of Medical Toxicology at the University of Southern California in Los Angeles, CA. She completed her Emergency Medicine Residency training at Lehigh Valley Health Network and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix, AZ. She is the Course Director for the medical toxicology rotation at USC, Co-Founder of ACMT’s Women in Toxicology (WiT), and is host of podcast “Tox in Ten” and co-host of podcast “Tox in Ten ACMT Highlights”

Kevin Osterhoudt, MD, FACMT

Medical Director, The Poison Control Center, Children’s Hospital of Philadelphia

Osterhoudt.jpgKevin Osterhoudt, MD, FACMT is the medical director at The Poison Control Center at the Children’s Hospital of Philadelphia and is a past member of the Board of Directors of ACMT. Dr. Osterhoudt is Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania where he is an Associate Scholar within the Center for Global Health. Kevin currently chairs the Education Committee of the International Section of ACMT.

Rama B. Rao, MD, FACMT

Associate Professor, Weill Cornell Medical College NYP

Rao.pngRama B. Rao is the Chief of the Division of Medical Toxicology at the New York Presbyterian Hospital and associate professor at the Weill Cornell Medical College.  She serves as Chair of AACT Forensic Special Interest Group, served on the American Board of Emergency Medicine Sub-board in Medical Toxicology, and has presented the annual assemblies of ACMT, AACT and EAPCCT.

Anne-Michelle Ruha, MD

Vice Chair Department of Medical Toxicology, Banner - University Medical Center Phoenix

ruha.bmpDr. Michelle Ruha is Vice Chair of the Department of Medical Toxicology at Banner – University Medical Center in Phoenix, Arizona. She is a Professor with the Departments of Internal Medicine and Emergency Medicine at the University of Arizona College of Medicine – Phoenix. Her clinical practice is focused on the acute care of patients with poisoning, envenomation and illness related to substance misuse disorders. She serves as faculty for both the Medical Toxicology and Addiction Medicine fellowships at the College of Medicine in Phoenix. Dr. Ruha is currently the Vice President of the American College of Medical Toxicology and the Associate Editor for the Journal of Medical Toxicology.

Veena Singla, PhD

Associate Director, Science & Policy, University of California, San Francisco Program on Reproductive Health and the Environment

no_avatar.jpgVeena Singla, PhD, is Associate Director of Science & Policy at the Program on Reproductive Health and the Environment. Her work focuses on informing policies with the most current scientific principles and data to reduce and prevent harmful environmental exposures. Her research focuses on indoor environmental quality and how exposure to multiple chemicals affects health outcomes, especially for vulnerable populations such as workers, pregnant women and young children. She specializes in the communication of complex scientific information at the intersection of research and policy, and has led work on groundbreaking policies which attempt to establish frameworks for safer chemical evaluation and substitution. She worked as a postdoctoral teaching fellow at Stanford University and as an adjunct faculty member at the University of San Francisco. She holds a bachelor’s degree from the University of California, Berkeley, and a PhD in cell biology from the University of California, San Francisco.

Aaron Skolnik, MD

Senior Associate Consultant, Department of Critical Care Medicine, Mayo Clinic

no_avatar.jpgAaron Skolnik received his MD from the University of Pittsburgh School of Medicine and completed residency in emergency medicine at Brigham and Women’s/Massachusetts General Hospital in Boston, MA. Thereafter, Aaron graduated from the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. He served as co-medical director of the Banner Poison and Drug Information Center and on the faculty of the University of Arizona College of Medicine, Phoenix. Subsequently, he completed additional fellowship training at the University of Pittsburgh in Critical Care Medicine and Neurocritical Care. He currently works as a multidisciplinary intensivist at the Mayo Clinic Arizona. He is board certified/eligible in Emergency Medicine, Medical Toxicology, Addiction Medicine, Critical Care Medicine, and Neurocritical Care.

Samuel J. Stellpflug, MD, FACMT

Director, Clinical Toxicology; Associate Professor of Emergency Medicine, Regions Hospital

Stellpflug.jpgSam is the Director of the Regions Hospital Clinical Toxicology Service (Saint Paul, MN) and the Twin Cities Med Tox Fellowship. He also practices, teaches, and learns as a faculty physician in the Regions Department of Emergency Medicine. He provides consultation for the Minnesota Poison Control System, and his academic appointment is through the University of Minnesota Medical School. Following medical school at the University of Wisconsin he completed a residency in emergency medicine at Regions Hospital and then the medical toxicology fellowship in the Twin Cities, a joint effort between the Regions Hospital / HealthPartners and the Minnesota Poison Control System. Sam's research interest is in treatment of poison-induced cardiogenic shock, among other things.


Henry Swoboda, MD

Assistant Professor, Departments of Emergency Medicine and Psychiatry, Rush University Medical Center

no_avatar.jpgHenry Swoboda, MD is board certified Emergency Medicine, Medical Toxicology, and Addicition Medicine and practices at Rush University Medical Center in Chicago, IL. He is also a certified medical review officer. He is core faculty in the Rush Emergency Medicine Residency Program, faculty in the Addiction Medicine Fellowship Program, and is affiliated with the Toxikon Consortium Toxicology Fellowship and the Illinois Poison Center. Dr. Swoboda is Director of the Rush Medical Toxicology consult service through the Department of Emergency Medicine and Co-director of the Substance Use Intervention Team, a multi-disciplinary Addiction Medicine consult service and outpatient clinic through the Department of Psychiatry.

Paul Wax, MD, FACMT

Executive Director, American College of Medical Toxicology

Wax_Paul.jpgDr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.
Along with his part time role as the Executive Director of ACMT, Dr. Wax is a Clinical Professor in Surgery (Emergency Medicine) at the University of Texas, Southwestern School of Medicine where he is a member of the Section of Medical Toxicology and Director of the Medical Toxicology Clinic. Before joining ACMT in 2008 as its Executive Director, and the University of Texas Southwestern in 2006 as a part-time faculty member, Dr. Wax had faculty appointments in the Departments of Emergency Medicine at the University of Rochester School of Medicine from 1991-2001 and the University of Arizona School of Medicine from 2001-2006. Dr. Wax previously served on the Board of Directors of ACMT from 1998-2008 serving as ACMT President from 2006-2008. During this tenure he chaired the ACMT Education Committee from 1998-2002. From 2002-2006 Dr. Wax served as the National Director of ACMT's Consultation Network to support the ATSDR Regional Offices and was co-founder of ACMT’s Chemical Agent of Opportunity course. From 1997-2006 Dr. Wax also served as one of the American Board of Emergency Medicine’s appointee’s on the Medical Toxicology Subboard. During this time Dr. Wax served as Editor of the Medical Toxicology Board Certification Examination as well as Chairman of the Subboard, and was also the primary author of the 2004 Core Content of Medical Toxicology. Dr. Wax has also served as a consultant to the Centers for Disease Control NCEH’s Division of Laboratory Sciences and was a member of NCEH/ATSDR Board of Scientific Counselors from 2006-2008.  

Tim Wiegand, MD, FACMT

Associate Professor of Emergency Medicine, University of Rochester Medical Center

Wiegand_Timothy.jpgTim Wiegand MD, DABAM, FACMT, FAACT attended Iowa State University and graduated with Honors and Distinction in 1995. He received his MD from the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin in 2004. Dr. Wiegand completed a categorical Internal Medicine residency at Hennepin County Medical Center, Minneapolis, Minnesota and completed fellowship training in Medical Toxicology and Clinical Pharmacology at the University of California, San Francisco in 2006 and 2007 respectively. Dr. Wiegand also became Board Certified in Addiction Medicine in 2015. He was the Medical Director of the Rochester Poison Center until 2010 and currently serves as the Director of Toxicology and of the Toxicology Consult Service at the University of Rochester Medical Center. Dr. Wiegand is an Associate Clinical Professor in the Department of Emergency Medicine at URMC and also a volunteer faculty member of the SUNY Upstate Medical Toxicology Fellowship program. Dr. Wiegand's research interests include billing, reimbursement and effectiveness of Medical Toxicology practice models, warning signs for suicide attempt in particular the use and involvement of alcohol or drugs in a suicide attempt and he is involved with wide variety of surveillance and research projects involving the bedside toxicology Registry the ACMT Toxic Case Registry.

David Wood, MD

Consultant Physician and Clinical Toxicologist, Guy's and St Thomas' NHS Foundation Trust

Wood.jpgDr David Wood is Consultant Physician and Clinical Toxicologist at Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK and a Reader in Clinical Toxicology at King’s College London, London, UK. He was a trustee of the British Pharmacological Society and member (clinical representative) of their council from 2012 to 2015. He supervises UK trainees in Clinical Pharmacology and Therapeutics and Clinical Toxicology, as well as hosting trainees from Europe and the USA undertaking Clinical Toxicology training placements. He has a clinical, research and academic interest in the epidemiology and patterns of use of and acute/chronic harms related to established recreational (illicit) drugs, new psychoactive substances (NPS) and misused prescription medicines. He has established a network of specialist emergency departments centres across Europe through the European Drug Emergencies Network (Euro-DEN) Plus project. Together with the RADARS System, he monitors the misuse of prescription medicines through a combination of consumer marketing panel based population level surveys and web monitoring to qualitatively understand discussion around misuse. He is a co-opted member of the UK Advisory Council on the Misuse of Drugs (ACMD) and expert advisor to the European Monitoring Centre for Drugs and Drug Addiction (ECMDDA) and the United Nations Office on Drugs and Crime (UNODC).